# Welcome to the Servier website.

Use the search field to explore our articles and resources.

## Our latest news

- **Therapeutic adherence at the forefront of the new #BecauseISaySo campaign** 2 September 2026 [Link](/content/en/newsroom/therapeutic-adherence-hypertension-becauseisayso-campaign/index.html)
- **Understanding clinical trials** 28 August 2026 [Link](/content/en/newsroom/folders/understanding-clinical-trials/index.html)
- **Sarah’s story, Senior Clinical Operations Project Manager, Australia** 27 August 2026 [Link](/content/en/newsroom/weareservier/careers-ambassadors-sarah-australia/index.html)
- **Paula’s story, Medical Representative, Colombia** 27 August 2026 [Link](/content/en/newsroom/weareservier/careers-ambassadors-paula-colombia/index.html)
- **Élodie’s story, Organic & Medicinal Chemistry Technician, France** 27 August 2026 [Link](/content/en/newsroom/weareservier/careers-ambassadors-elodie-france/index.html)
- **Qiang’s story, QC Engineer, China** 27 August 2026 [Link](/content/en/newsroom/weareservier/careers-ambassadors-qiang-china/index.html)
- **How can we minimize the environmental footprint of a medicine without compromising its quality or safety?** 17 August 2026 [Link](/content/en/newsroom/minimize-environmental-footprint-medicine/index.html)
- **#LegsFirst: Servier committed to make leg health a daily priority** 6 August 2026 [Link](/content/en/newsroom/legsfirst-leg-health/index.html)
- **Patient Voices: Caregiving, a full-time commitment** 22 July 2026 [Link](/content/en/newsroom/patient-voices-caregiving-glioma/index.html)
- **Oncology innovation gains momentum in Japan** 17 July 2026 [Link](/content/en/newsroom/oncology-innovation-japan/index.html)
- **Servier completes the acquisition of Edgewise Therapeutics’ Muscular Dystrophy Business** 13 July 2026 [Link](/content/en/newsroom/acquisition-edgewise-therapeuticsmuscular-dystrophy-business/index.html)
- **Venous disease: when the circulatory system is affected** 9 July 2026 [Link](/content/en/newsroom/folders/venous-disease-when-the-circulatory-system-is-affected/index.html)
- **One Job, Many Stories: celebrating women engineers across Servier Industry!** 23 June 2026 [Link](/content/en/newsroom/one-job-many-stories-women-engineers-industry/index.html)
- **Seedpods Day: Honoring Servier’s junior researchers at Paris-Saclay** 17 June 2026 [Link](/content/en/newsroom/seedpods-day-honoring-junior-researchers/index.html)
- **Servier x L’ADN: More complex, more open: innovation as an archipelago** 12 June 2026 [Link](/content/en/newsroom/adn-complex-open-innovation-archipelago/index.html)
- **Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders** 10 June 2026 [Link](/content/en/newsroom/n-lorem-foundation-rare-neurodevelopmental-disorders/index.html)
- **Servier joins the United Nations Global Compact: A milestone for our sustainability commitment** 9 June 2026 [Link](/content/en/newsroom/united-nations-global-compact-sustainability/index.html)
- **Servier to Acquire Edgewise Therapeutics’ Muscular Dystrophy Business** 1 June 2026 [Link](/content/en/newsroom/acquisition-edgewise-therapeutics-muscular-dystrophy-business/index.html)

## Our solutions for patients

### Three key therapeutic areas

Involving patients enables us to design suitable therapeutic solutions in each of our three therapeutic areas.

### Cancers
A focused and innovative player developing targeted therapies to treat cancer

### Cardio metabolism
Over 70 years of unwavering commitment in cardiometabolism and venous diseases

### Neurology
Addressing major medical needs in rare neurological disorders

## Colorectal cancer: Screening still comes too late

Colorectal cancer is a common disease. It is one of the most frequently diagnosed cancers in the world – ranking third behind lung cancer and liver cancer – and it affects almost as many women as men. [Read more](/content/en/newsroom/folders/colorectal-cancer-screening-too-late/index.html)

## Cholangiocarcinoma, a rare tumor of the bile duct

The malignant tumors in cholangiocarcinoma, a type of cancer of the bile duct, are rare and aggressive. [Read more](/content/en/newsroom/folders/cholangiocarcinoma-a-rare-tumor-of-the-bile-duct/index.html)

## Glioma: a rare, aggressive brain tumor

Glioma is the most common primary brain tumor in adults. [Read more](/content/en/newsroom/folders/glioma-aggressive-brain-tumor/index.html)